Bioequivalence and pharmacokinetic comparison between extended release capsules of carvedilol phosphate 40 mg: An open label, balanced, randomized-sequence, single-dose, two-period crossover study in healthy male volunte
open-labeled, balanced, single-dose, two treatment, two period, two sequence, randomized two way crossover study was conducted in 18 healthy adult male subjects to determine the pharmacokinetic, bioavailability

